- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BLINCYTO (Blinatumomab)
Total 118 results
-
University of Maryland, BaltimoreActive, not recruitingMixed Phenotype Acute Leukemia (MPAL) | Measurable Residual Disease (MRD)United States
-
Stichting Hemato-Oncologie voor Volwassenen NederlandActive, not recruitingALL, AdultNetherlands, Belgium
-
Goethe UniversityCompletedALL, Recurrent, AdultGermany
-
Prof. Christina PetersAmgenTerminatedMinimal Residual Disease | ALL, ChildhoodNorway, Spain, Denmark, Austria, Belgium, Czechia, France, Italy, Poland, Slovakia
-
AmgenNot yet recruitingB Precursor Acute Lymphoblastic Leukemia | Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
-
Institute of Hematology and Blood Transfusion,...CZECRIN - Czech Clinical Research Infrastructure NetworkCompletedNewly Diagnosed | Lymphoblastic Leukemia, Acute, Adult | Ph Negative ALLCzechia
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
Goethe UniversityRecruiting
-
Massachusetts General HospitalAmgenCompletedNon-Hodgkin LymphomaUnited States
-
Goethe UniversityUniversity Hospital Schleswig-HolsteinRecruiting
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaUnited States, Germany, Austria, Canada, France, Italy, Netherlands
-
AmgenRecruitingB Cell Precursor Acute Lymphoblastic LeukemiaJapan, Australia, Spain, United States, Italy, Germany, France, Turkey, Canada, Netherlands, Austria
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
M.D. Anderson Cancer CenterAmgenCompletedAcute Lymphoblastic LeukemiaUnited States
-
AmgenAmgen Astellas Biopharma K.K.CompletedRelapsed Refractory B Precursor Acute Lymphoblastic LeukemiaJapan
-
Amgen Research (Munich) GmbHCompleted
-
Amgen Research (Munich) GmbHCompletedDiffuse Large B-cell LymphomaGermany
-
Ascentage Pharma Group Inc.RecruitingMyeloid Leukemia | Chronic Myeloid Leukemia | Philadelphia Positive Acute Lymphoblastic Leukemia | Leukemia, Myeloid, Chronic | B Cell Precursor Type Acute LeukemiaUnited States
-
AmgenCompletedRelapsed/Refractory Philadelphia Positive B-precursor ALLFrance, United States, Germany, Italy, United Kingdom
-
Amgen Research (Munich) GmbHCompletedB-cell Acute Lymphoblastic LeukemiaAustria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaUnited States, United Kingdom, Germany, Spain, France, Italy
-
Ho Joon ImNot yet recruitingAcute Lymphoid LeukemiaKorea, Republic of
-
Amgen Research (Munich) GmbHCompletedAcute Lymphoblastic LeukemiaGermany
-
Children's Hospital Medical Center, CincinnatiWithdrawnLymphoma, B-Cell | Leukemia, B-cellUnited States
-
Amgen Research (Munich) GmbHCompletedNon-Hodgkin's Lymphoma, RelapsedGermany
-
AmgenRecruitingNewly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)Japan, Australia, Denmark, Netherlands, Taiwan, Switzerland, Canada, France, United States, Austria, Italy, Spain, Sweden, Belgium, Hungary, Finland, Greece, Turkey, Portugal, Romania, Germany, Bulgaria, Mexico, United Kingdom
-
Imugene LimitedRecruiting
-
AmgenNo longer availableRelapsed/Refractory B-Precursor Acute Lymphoblastic LeukemiaUnited States, Italy, Germany, Austria, France, Switzerland, United Kingdom
-
University of California, San DiegoMerck Sharp & Dohme LLC; AmgenActive, not recruitingB-Cell Acute Lymphoblastic Leukemia, AdultUnited States
-
Medical College of WisconsinUniversity of Wisconsin, Madison; AmgenRecruitingB-cell Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | B-Cell ALL, ChildhoodUnited States
-
Cedars-Sinai Medical CenterAmgenActive, not recruitingB-ALL | B-Cell Acute Lymphoblastic Leukaemia | ALL, AdultUnited States
-
AmgenRecruitingB-precursor Acute Lymphoblastic LeukemiaUnited States
-
AmgenCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AmgenActive, not recruitingAcute Lymphoblastic Leukemia | B-cell Non Hodgkin Lymphoma | Pre B-Cell Acute Lymphoblastic LeukaemiaUnited States
-
Chen SuningRecruitingALL, Adult | Philadelphia-Negative ALLChina
-
Cardiff UniversityNot yet recruitingAcute Lymphoblastic Leukemia, Adult
-
AmgenTerminatedRelapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaUnited States, France, Italy, Belgium, Canada, Mexico, Germany, Korea, Republic of, United Kingdom, Taiwan, Australia, Spain, Austria, Israel, Czechia, Greece, Russian Federation, Poland, Turkey, Bulgaria, Ireland
-
Novartis PharmaceuticalsWithdrawn
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
PETHEMA FoundationTerminatedPhiladelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALLSpain
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingAcute Lymphoid Leukemia | Philadelphia Chromosome-Negative B-Cell PrecursorItaly
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
University of British ColumbiaAmgenTerminatedMinimal Residual Disease | B-cell Adult Acute Lymphoblastic Leukemia | Stem Cell LeukemiaCanada
-
Seoul National University HospitalAmgenRecruitingMinimal Residual Disease | Pediatric ALL, B CellKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingAcute Lymphoblastic Leukemia, Adult B-CellFrance
-
A.O. Ospedale Papa Giovanni XXIIIActive, not recruitingIndolent Non-Hodgkin Lymphomas/Chronic Lymphocytic LeukemiaItaly
-
Sichuan UniversityNot yet recruiting
-
Sichuan UniversityRecruitingLeukemia, LymphoidChina
-
AmgenCompletedAcute Lymphoblastic LeukemiaGermany, United States, France, Australia, Spain, Italy, Netherlands, Austria, United Kingdom
-
National Research Center for Hematology, RussiaRecruitingPrecursor Cell Lymphoblastic Leukemia-LymphomaRussian Federation